A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement
In late February 2009, the U.S. Food & Drug Administration (FDA) ordered a Black Box Warning for drugs containing the active ingredient metoclopramide. Reglan is a brand name for a drug containing metoclopramide. Over two million people in the U.S. use this medication. The Black Box warning is the most serious warning the FDA gives.
Reglan is designed to treat acid reflux disease, heartburn, gastroesophageal reflux disorder and symptoms of diabetic gastroparesis. Reglan works by increasing the contractions of both the stomach and small intestine. This helps with the passage of foods and it speeds up the rate that the stomach empties into the intestines. There are several different forms of Reglan, including tablets, oral disintegrating tablets and injections. All three types now have the Black Box Warning.
Reglan is only recommended for short-term use. Patients should only take Reglan for 1-3 months. Long-term use of Reglan can lead to very serious side effects. Reglan has been shown to cause mild to severe depression in patients. In addition, Reglan can also cause Parkinson-like symptoms, such as tremor, rigidity and slow movements. The most severe side effect is tardive dyskinesia.
Tardive dyskinesia is a neurological disorder, which causes involuntary and repetitive movements. Patients suffer from jerky movements in the jaw, mouth, tongue, face, arms, and legs.
The involuntary movements have decreased or stopped in a few patients after they stopped taking Reglan. Unfortunately for most patients, tardive dyskinesia is irreversible and they will continue to suffer from this disorder. There is not any known treatment for tardive dyskinesia. Most people will suffer from this disorder for the rest of their lives. The people most at risk for developing tardive dyskinesia are older, female patients. Risk of developing tardive dyskinesia is also linked to the dosage and length of time patients took Reglan.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING THE USE OF REGLAN OR ANY OTHER PRESCRIPTION DRUGS.
Because of the risk of developing tardive dyskinesia, the FDA ordered a Black Box Warning for the Reglan label. In addition, Reglan is required to provide a Medication Guide to patients before they take the drug.
If you believe that you or a loved one has suffered as a result of taking Reglan, you may want to speak with a personal injury attorney regarding a potential claim. An injury lawyer familiar with new developments in the investigation of Reglan may be able to help you make important personal and legal decisions.
Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.